Health Condition 1: J309- Allergic rhinitis, unspecified
Conditions
Interventions
Intervention1: Histaminum hydrochloricum: Medicine will be administered in ascending LM potency,3 dose a week on alternate days for a period of 6 months
potency change is done as per the requirement o
Sponsors
Sarada Krishna Homoeopathic Medical College
Eligibility
Inclusion criteria
Inclusion criteria: Patient clinically diagnosed with allergic rhinitis. Patients having elevated serum IgE levels above 200 Iu/ml Age limit 5 to 50 years Both genders are included
Exclusion criteria
Exclusion criteria: Patients with only DNS, nasal polyp associated rhinitis is excluded. Patients with serious extended chest infections are excluded. Patients having other IgE mediated hypersensitivity reactions like urticaria, atopic dermatitis. Are excluded from the study Pregnant and breast-feeding women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Study is expected to show reduction in symptoms and recurrence of the allergic rhinitis in patients under Histaminum Hydrochloricum than control group Lowering of serum IgE and AEC levels in group under homoeopathic medication Timepoint: 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in quality of life of the patientTimepoint: 6 months | — |
Countries
India
Contacts
Public ContactDr N V Sugathan
Sarada krishna Homoeoapthic Medical College
Outcome results
None listed